logo-loader
NYSE:ATNM

Actinium Pharmaceuticals Inc

Receive alerts
Market:
NYSE
Market Cap:
$124.08 m
Price
0.31 USD
Change
-4.85%
52 weeks high
0.62
52 weeks low
0.16

In brief

Actinium is a leading biotechnology company developing targeted radioimmunotherapies for the treatment of cancer patients with unmet needs.